Severe Acute Respiratory Syndrome Coronavirus 2-Specific Monoclonal Antibody for the Treatment of Mild to Moderate Coronavirus Disease 2019 in Cancer Patients: A Single-Center Experience.

Authors :: Puing AG
Ho S
Frankel P
Tegtmeier B
Martin A
Ross J
Nanayakkara D
Dickter J
Seto T
Nakamura R
Taplitz R
Dadwal S
Source :: The Journal of infectious diseases [J Infect Dis] 2022 Jan 18; Vol. 225 (2), pp. 352-354.
Publication Year :: 2022

Subjects :: Antibodies, Monoclonal therapeutic use
Antibodies, Viral
Humans
SARS-CoV-2
COVID-19
Neoplasms

Full Text Access

Tools